These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2627615)

  • 41. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
    Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allogeneic bone marrow transplantation using unrelated marrow donors.
    Fay JW; Collins RH; Piñeiro L
    Bone Marrow Transplant; 1993; 11 Suppl 1():81-2. PubMed ID: 8448557
    [No Abstract]   [Full Text] [Related]  

  • 43. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
    Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
    Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of combination of biologic markers (C-reactive protein, neopterin, and microalbuminuria) in the follow-up of kidney transplantation in children: four years of clinical experience.
    Fischbach M; Desprez P; Mengus L; Christman D; Marcellin L; Chenard MP; Hamel G; Koehl C; Simeoni U; Boudjema K
    Transplant Proc; 1994 Feb; 26(1):72-4. PubMed ID: 8109029
    [No Abstract]   [Full Text] [Related]  

  • 48. Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: the experience at Huddinge Hospital.
    Aschan J; Ringdén O; Ljungman P; Hägglund H; Klaesson S; Dalianis T; Remberger M
    Transplant Proc; 1995 Dec; 27(6):3531-2. PubMed ID: 8540086
    [No Abstract]   [Full Text] [Related]  

  • 49. [Diagnostic validity of clinico-biochemical parameters in postoperative monitoring of heart transplant patients].
    Hölzel W; Müller MM
    Z Med Lab Diagn; 1989; 30(1):13-4. PubMed ID: 2470212
    [No Abstract]   [Full Text] [Related]  

  • 50. Increased hepatocyte growth factor in serum in acute graft-versus-host disease.
    Okamoto T; Takatsuka H; Fujimori Y; Wada H; Iwasaki T; Kakishita E
    Bone Marrow Transplant; 2001 Jul; 28(2):197-200. PubMed ID: 11509938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages.
    Niederwieser D; Herold M; Woloszczuk W; Aulitzky W; Meister B; Tilg H; Gastl G; Bowden R; Huber C
    Transplantation; 1990 Oct; 50(4):620-5. PubMed ID: 2171163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring of serum neopterin in renal transplant recipients.
    Lee PH; Huang MT; Chung YC; Hu RH; Tzeng SS; Lee CJ; Lee CS
    J Formos Med Assoc; 1992 Dec; 91(12):1209-12. PubMed ID: 1363646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neopterins as markers in bone marrow transplantation.
    MacWhannell A; Leeming RJ; Davies S; Franklin IM; Pollock A
    Lancet; 1988 Apr; 1(8589):829. PubMed ID: 2895348
    [No Abstract]   [Full Text] [Related]  

  • 54. [The immune system in pregnancy. Neopterin levels and their significance].
    Indraccolo SR; Brandi S; Centioni G; Cecchi A
    Minerva Ginecol; 1992 Mar; 44(3):79-82. PubMed ID: 1565285
    [No Abstract]   [Full Text] [Related]  

  • 55. [Does the determination of serum neopterin secure blood transfusion?].
    Wilmer A; Tilg H; Vogel W
    Dtsch Med Wochenschr; 1992 May; 117(19):765. PubMed ID: 1576945
    [No Abstract]   [Full Text] [Related]  

  • 56. [Neopterin today].
    Huber C; Troppmair J; Rokos H; Curtius HC
    Dtsch Med Wochenschr; 1987 Jan; 112(3):107-13. PubMed ID: 2433118
    [No Abstract]   [Full Text] [Related]  

  • 57. Neopterin as a new biochemical marker in the clinical monitoring of bone marrow transplant recipients.
    Niederwieser D; Huber C; Gratwohl A; Bannert P; Fuchs D; Hausen A; Reibnegger G; Speck B; Wachter H
    Transplantation; 1984 Nov; 38(5):497-500. PubMed ID: 6388072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum and urinary neopterin as markers in renal transplant patients.
    Kameoka H; Takahara S; Takano Y; Moutabarrik A; Kokado Y; Ishibashi M; Sonoda T; Okuyama A
    Int Urol Nephrol; 1994; 26(1):107-15. PubMed ID: 8026915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Laboratory diagnosis in heart transplant patients].
    Müller MM
    Z Med Lab Diagn; 1989; 30(1):11-2. PubMed ID: 2470211
    [No Abstract]   [Full Text] [Related]  

  • 60. Simultaneous determination of serum neopterin and C-reactive protein as markers of infection in heart-transplant recipients.
    Myara I; Atger V; Cosson C; Guillemain R; Amrein C; Dreyfus G; Moatti N
    Clin Chem; 1989 Jun; 35(6):1258-9. PubMed ID: 2659220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.